ASXL1 and chronic myelomonocytic leukemia: In the current study, we found that the expression of ASXL1 significantly decreased in the BMSCs of chronic myelomonocytic leukemia patients (CMML-BMSCs) compared with healthy donors (HD-BMSCs).